The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodies

Published:2022-11-16 Issue:1 Volume:13 Page:2012-2021
ISSN:2150-5594
Container-title:Virulence
language:en
Short-container-title:Virulence

Author:

Liu Kexin¹²,Li Jinyu³,Xu Gaosi¹

Affiliation:

1. Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China

2. Grade 2019, The Second Clinical Medical College of Nanchang University, Nanchang, Jiangxi, China

3. Grade 2020, The First Clinical Medical College of Nanchang University, Nanchang, Jiangxi, China

Funder

The Nature Science Foundation of Jiangxi Province

National Natural Science Foundation of China

Kidney Disease Engineering Technology Research Centre Foundation of Jiangxi Province

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Parasitology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21505594.2022.2146380

Reference33 articles.

1. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients

2. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

3. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

4. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

5. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorizations to January 2024;Expert Review of Vaccines;2024-09-11

2. Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience;Frontiers in Immunology;2023-11-01

3. Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments;Frontiers in Immunology;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3